Ganciclovir Capsules
FreeGanciclovir capsules (commonly found in 250 mg and 500 mg strengths) contain the active antiviral drug ganciclovir, a synthetic guanine derivative used to treat and prevent cytomegalovirus (CMV) infections
Oseltamivir Tablet
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Hard Gelatin Capsule, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the hygroscopic phosphate salt.
Active Ingredient Strength Primary Clinical Function Oseltamivir Phosphate USP/Ph.Eur. 75 mg (Equivalent to Oseltamivir free base) Global Standard: Target adult dose for rapid treatment and prophylaxis of Influenza A/B. Excipients Pregelatinized Starch / Croscarmellose Sodium / Povidone / Sodium Stearyl Fumarate Diluent / Superdisintegrant (Engineered for immediate gastric capsule rupture and rapid systemic absorption) *Pack Sizes: 1×10 Blisters (Optimized perfectly for the standard 5-day acute treatment regimen of two capsules daily).
Ribavirin Capsules
FreeRibavirin capsules are antiviral medications typically used in combination with other drugs (like interferon or sofosbuvir) to treat chronic Hepatitis C. They are most commonly available in a 200 mg strength, though 100 mg versions also exist.
Ribavirin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or heavy-density PVC/PVDC blister strips to ensure the stability of the active nucleoside analog and protect handlers from exposure.
Active Ingredient Strength Primary Clinical Function Ribavirin USP/Ph.Eur. 200 mg Global Clinical Standard: Base titration unit for precise, weight-based antiviral dosing. Ribavirin USP/Ph.Eur. 400 mg High-dose unit to drastically improve pill-burden compliance in heavy patients. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Povidone / Magnesium Stearate Diluent / Superdisintegrant / Binder (Engineered for immediate gastric dissolution and rapid systemic absorption) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for high-dose, weight-based daily regimens requiring 4 to 6 tablets per day).
Sofosbuvir & Ledipasvir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles containing exactly 28 tablets to perfectly align with strict clinical dispensing cycles.
Active Ingredient Strength Primary Clinical Function Sofosbuvir INN/Ph.Eur. 400 mg NS5B RNA polymerase inhibition to terminate viral RNA chain synthesis. Ledipasvir INN/Ph.Eur. 90 mg NS5A protein inhibition to halt viral replication and physical virion assembly. Excipients Copovidone / Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Magnesium Stearate Binder / Diluent / Superdisintegrant (Engineered for strict synchronized gastric dissolution) Sofosbuvir & Velpatasvir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles containing exactly 28 tablets to perfectly align with strict 12-week clinical dispensing cycles.
Active Ingredient Strength Primary Clinical Function Sofosbuvir INN/Ph.Eur. 400 mg NS5B RNA polymerase inhibition to terminate viral RNA chain synthesis. Velpatasvir INN/Ph.Eur. 100 mg NS5A protein inhibition to halt viral replication and physical virion assembly. Excipients Copovidone / Microcrystalline Cellulose / Croscarmellose Sodium / Magnesium Stearate Binder / Diluent / Superdisintegrant (Engineered for strict synchronized gastric dissolution) Sofosbuvir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles or ultra-dense Alu-Alu blister strips to ensure the absolute chemical stability of the nucleotide analog.
Active Ingredient Strength Primary Clinical Function Sofosbuvir INN/Ph.Eur. 400 mg Global Standard: Base NS5B polymerase inhibition for daily combination HCV therapy. Excipients Mannitol / Microcrystalline Cellulose / Croscarmellose Sodium / Colloidal Silicon Dioxide / Magnesium Stearate Diluent / Superdisintegrant / Glidant (Engineered for immediate gastric dissolution and high bioavailability) Valganciclovir Tablets
FreeProduct Composition & Strength
We supply this product as a Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles for chronic dispensing regimens.
Active Ingredient Strength Primary Clinical Use Valganciclovir Hydrochloride USP/Ph.Eur. 450 mg (Equivalent to Valganciclovir free base) Standard Adult Dose for CMV retinitis induction/maintenance and transplant prophylaxis. Excipients Povidone / Crospovidone / Microcrystalline Cellulose / Stearic Acid Binder / Superdisintegrant / Diluent (Ensures rapid gastric dispersion and prodrug integrity)
Showing all 8 results
